Home Cart Sign in  
Chemical Structure| 402957-28-2 Chemical Structure| 402957-28-2

Structure of Telaprevir
CAS No.: 402957-28-2

Chemical Structure| 402957-28-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Telaprevir (VX-950) is a highly selective, reversible, and potent peptidomimetic inhibitor of the HCV NS3-4A protease, with a steady-state inhibitory constant (Ki) of 7 nM against a genotype 1 (H strain) NS3 protease domain plus an NS4A cofactor peptide. Telaprevir also inhibits SARS-CoV-2 3CLpro activity.

Synonyms: VX-950; LY570310; Incivo

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Telaprevir

CAS No. :402957-28-2
Formula : C36H53N7O6
M.W : 679.85
SMILES Code : O=C(N([C@@H]1C(N[C@H](C(C(NC2CC2)=O)=O)CCC)=O)C[C@@]3(CCC[C@@]31[H])[H])[C@@H](NC([C@@H](NC(C4=NC=CN=C4)=O)C5CCCCC5)=O)C(C)(C)C
Synonyms :
VX-950; LY570310; Incivo
MDL No. :MFCD11616089
InChI Key :BBAWEDCPNXPBQM-GDEBMMAJSA-N
Pubchem ID :3010818

Safety of Telaprevir

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Target
  • HCV Protease

    HCV NS3-4A serine protease, IC50:0.35 μM

In Vitro:

Cell Line
Concentration Treated Time Description References
muscle cells 1.9 μM inhibit EV-D68 replication PMC10231134
neuronal cells 1.9 μM inhibit EV-D68 replication PMC10231134
lung cells 1.9 μM inhibit EV-D68 replication PMC10231134
Non-diabetic human islets 1.5 μM or 150 μM 24 h To evaluate the effects of telaprevir on human β-cell proliferation and apoptosis. Telaprevir significantly increased human β-cell proliferation levels (~3-fold) and significantly reduced apoptosis. PMC10834355
SKBR3 cells 20 µM 72 h To evaluate the effect of Telaprevir on FOXA1 levels. Results showed that Telaprevir reduced FOXA1 levels. PMC9533686
MCF-7 cells 20 µM 72 h To evaluate the effect of Telaprevir on ERα and FOXA1 levels. Results showed that Telaprevir reduced FOXA1 and ERα levels. PMC9533686
Huh7.5.1 cells 10 μM 5 days Evaluation of the antiviral effect of Telaprevir with entry inhibitors, showing synergistic inhibition of HCV infection PMC4345833

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
NSG mice Human islet transplantation model Osmotic pumps 30 μg/kgor 300 μg/kg Once daily for 4 weeks To evaluate the effects of telaprevir on human β-cell proliferation and apoptosis in vivo. High-dose telaprevir significantly increased Ki67+ β-cell numbers and decreased TUNEL+ β-cell numbers. PMC10834355
Swiss Webster mice EV-D68-associated acute flaccid myelitis model Intraperitoneal injection 35 mg/kg Daily for 14 days Evaluate the efficacy of Telaprevir against EV-D68-associated acute flaccid myelitis PMC10231134
ICR-C/OTg mice HCV infection model Intraperitoneal injection 200 mg/kg Once daily for 2 weeks To evaluate the inhibitory effect of Telaprevir on HCV replication PMC4152738
Humanized uPA/SCID mice HCV Jc1 infection model Oral 300 mg/kg Twice daily for 2 weeks Evaluation of the antiviral effect of Telaprevir combined with anti-SR-BI mAb, showing that combination therapy was more effective than monotherapy PMC4345833

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01816490 HIV Hepatitis... More >> C Less << Phase 2 Completed - Switzerland ... More >> Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich Zurich, Switzerland, 8091 Less <<
NCT01604291 - Completed - Israel ... More >> Haemek Hospital; Gastroenterology Afula, Israel, 18101 Barzilai MC; Gastroenterology Ashkelon, Israel, 78278 Soroka Medical Center; Gastroenterology Beer Sheva, Israel, 84105 Hillel Yaffe Hospital; Gastroenterology Hadera, Israel, 38100 Rambam Medical Center; Gastroenterology - Liver Unit Haifa, Israel, 31096 Bnei-Zion Medical Center; Gastroenterology Haifa, Israel, 33394 Carmel Hospital; Liver Unit Haifa, Israel, 34362 Wolfson Hospital; Gastroenterology Unit Holon, Israel, 58100 Shaare Zedek Hospital Liver Unit; Liver Unit Jerusalem, Israel, 91031 Hadassah Hospital; Liver Unit Jerusalem, Israel, 91120 Meir Medical Center; Liver Unit Kfar Saba, Israel, 44281 Western Galilee Hospital - Nahariya Nahariya, Israel, 22100 Holy Family Medical Center; Liver Unit Nazareth, Israel Hasharon Mc; Gastroenterology Petach Tikva, Israel Beilinson-Rabin Liver Unit; Liver Unit Petah Tiqwa, Israel Sheba Medical Center; Tel Hashomer Ramat Gan, Israel, 5262100 Kaplan Medical Center; Gastroenterology Unit Rehovot, Israel, 76100 Rebecca Sieff Medical Center; Liver Unit Safed, Israel, 13110 Tel-Aviv Sourasky Medical Center; Liver Unit Tel Aviv, Israel, 6423906 Poria Hospital; Gastroenterology Tiberias, Israel Assaf Harofeh; Gastroenterology Zerifin, Israel, 6093000 Less <<
NCT01508130 - Completed - -
NCT01508130 - Completed - -
NCT01648140 Hepatitis C, Chronic Phase 2 Completed - -
NCT01355289 Thrombocytopenia Phase 2 Completed - United States, California ... More >> Health Care Consultants Los Angeles, California, United States United States, Virginia Metropolitan Research Fairfax, Virginia, United States, 22031 Less <<
NCT01648140 - Completed - -
NCT01447446 - Completed - -
NCT02758509 - Completed - -
NCT01355289 - Completed - -
NCT00591214 Chronic Hepatitis C Phase 1 Completed - Japan ... More >> Toranomon Hospital Kawasaki City, Takatsu-ku, Japan Less <<
NCT01771653 - Completed - United States, Illinois ... More >> Southern Illinois University School of Medicine Springfield, Illinois, United States, 62701 Less <<
NCT01447446 - Completed - -
NCT00591214 - Completed - -
NCT00780910 Chronic Hepatitis C Phase 3 Completed - Japan ... More >> Toranomon Hospital Kawasaki City, Takatsu-ku, Japan Less <<
NCT00780910 - Completed - -
NCT00781274 Hepatitis C Phase 3 Completed - Japan ... More >> Toranomon Hospital Kawasaki City, Takatsu-ku, Japan Less <<
NCT01691235 - Withdrawn(No subjects enrolled... More >> due to delay in device production) Less << - United States, Illinois ... More >> The University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT01544582 - Completed - -
NCT00780416 Hepatitis C Phase 3 Completed - Japan ... More >> Toranomon Hospital Kawasaki City, Takatsu-ku, Japan Less <<
NCT00630058 Hepatitis C Phase 1 Completed - Japan ... More >> Toranomon Hospital Kawasaki City, Takatsu-ku, Japan Less <<
NCT01544582 - Completed - -
NCT01485991 Hepatitis C Phase 3 Completed - -
NCT00630058 - Completed - -
NCT02004379 - Completed - Spain ... More >> Hospital Universitario Doctor Negrín Las Palmas de Gran Canaria, Gran Canaria, Spain Hospital Comarcal Santa Ana Motril, Granada, Spain Hospital Universitario de Santiago de Compostela Santiago de Compostela, La Coruña, Spain Hospital Universitario Fundación Alcorcón Alcorcón, Madrid, Spain Hospital Son Espases Palma de Mallorca, Mallorca, Spain Hospital General Universitario Rafael Méndez Lorca, Murcia, Spain Agencia Sanitaria Costa del Sol Marbella, Málaga, Spain Hospital Universitario Nuestra Señora de la Candelaria Santa Cruz de Tenerife, Tenerife, Spain Hospital de Poniente Almería, Spain Hospital Torrecárdenas Almería, Spain Hospital Infanta Cristina Badajoz, Spain Hospital Universitario de Cruces Bilbao, Spain Hospital General de Ciudad Real Ciudad Real, Spain Hospital San Pedro de Alcántara Cáceres, Spain Hospital Puerta del Mar Cádiz, Spain Hospital Reina Sofía Córdoba, Spain Hospital Universitario de San Cecilio Granada, Spain Hospital Universitario Virgen de las Nieves Granada, Spain Hospital de Guadalajara Guadalajara, Spain Hospital Juan Ramón Jiménez Huelva, Spain Hospital San Jorge Huesca, Spain Complejo Hospitalario de Jaén Jaén, Spain Hospital Universitario A Coruña La Coruña, Spain Hospital de León León, Spain Hospital Ramón y Cajal Madrid, Spain Hospital Universitario de La Princesa Madrid, Spain Hospital Universitario La Paz Madrid, Spain Hospital Morales Meseguer Murcia, Spain Hospital Reina Sofía Murcia, Spain Hospital Universitario Virgen de la Arrixaca Murcia, Spain Hospital Universitario Carlos Haya Málaga, Spain Hospital Universitario Virgen de la Victoria Málaga, Spain Hospital Universitario Central de Asturias Oviedo, Spain Hospital Universitario de Salamanca Salamanca, Spain Hospital Universitario de Donostia San Sebastián, Spain Hospital Universitario de Valme Sevilla, Spain Hospital Universitario Virgen de la Macarena Sevilla, Spain Hospital Unviersitario Virgen del Rocío Sevilla, Spain Complejo Hospitalario de Toledo Toledo, Spain Hospital Arnau de Vilanova Valencia, Spain Hospital Clínico de Valencia Valencia, Spain Hospital General de Valencia Valencia, Spain Hospital la Fe Valencia, Spain Hospital Clínico Universitario de Valladolid Valladolid, Spain Hospital Universitario Río Hortega Valladolid, Spain Hospital de Zamora Zamora, Spain Hospital Clínico Universitario de Zaragoza Zaragoza, Spain Hospital Universitario Miguel Servet Zaragoza, Spain Less <<
NCT01485991 - Completed - -
NCT00781274 - Completed - -
NCT00621296 - Completed - -
NCT01743521 Hepatitis C, Chronic Phase 4 Completed - Australia, New South Wales ... More >> St Vincent's Hospital Sydney, New South Wales, Australia, 2010 Australia, South Australia Royal Adelaide Hospital Adelaide, South Australia, Australia, 5000 Less <<
NCT01743521 - Completed - -
NCT01532908 Hepatitis C Infection Phase 2 Terminated(The study was termi... More >>nated due to funding constraints) Less << - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New York Mount Sinai Hospital New York, New York, United States, 10029 United States, Texas The Liver Institute at Methodist Dallas Medical Center Dallas, Texas, United States, 75203 Less <<
NCT01641094 - Completed - Netherlands ... More >> Reinier de Graaf Ziekenhuis Delft, Zuid-Holland, Netherlands Erasmus Medical Center Rotterdam, Netherlands, 3015 CE Less <<
NCT00780416 - Completed - -
NCT01786382 Pharmacokinetic Assessments in... More >> Healthy Volunteers Less << Phase 1 Completed - United States, Wisconsin ... More >> Spaulding Clinical Research West Bend, Wisconsin, United States, 53095 Less <<
NCT01577069 - Completed - France ... More >> Hôpital du haut-Lévêque Pessac, France, 33604 Less <<
NCT02452814 - Completed - United States, Texas ... More >> Methodist Transplant Physicians Dallas, Texas, United States, 75203 Research Specialists of Texas Houston, Texas, United States, 77030 Puerto Rico Fundacion de Investigacion de Diego San Juan, Puerto Rico, 00927 Less <<
NCT01704521 Chronic Hepatitis C ... More >> Hemophilia Less << Phase 1 Completed - United States, Ohio ... More >> UC Physicians Company Cincinnati, Ohio, United States, 45267 Less <<
NCT01704521 - Completed - -
NCT00251199 Hepatitis C Phase 1 Completed - Germany ... More >> Call for information Homburg/Saar, Germany Netherlands Call for information Amsterdam, Netherlands Less <<
NCT01718158 Hepatitis C Phase 3 Completed - -
NCT01854528 Chronic Hepatitis C Infection Phase 3 Completed - -
NCT01582035 Hepatitis C Phase 1 Completed - Germany ... More >> Berlin, Germany München, Germany Less <<
NCT01854528 - Completed - -
NCT01563328 Infection, Human Immunodeficie... More >>ncy Virus Less << Phase 1 Completed - United States, Texas ... More >> GSK Investigational Site Austin, Texas, United States, 78744 Less <<
NCT00509210 Hepatic Insufficiency Phase 1 Completed - United States, Indiana ... More >> Indiana University, Department of Medicine,Division of Gastroenterology / Hepatology Indianapolis, Indiana, United States, 46202 Less <<
NCT01482390 Hepatitis C Phase 2 Completed - -
NCT01514890 - Completed - France ... More >> Hôpital Henri Mondor Créteil, France, 94000 Less <<
NCT01581138 Chronic Hepatitis C Virus Phase 2 Completed - United States, Alabama ... More >> Birmingham, Alabama, United States United States, California Anaheim, California, United States Riverside, California, United States San Diego, California, United States United States, Colorado Englewood, Colorado, United States United States, Florida Orlando, Florida, United States United States, Georgia Marietta, Georgia, United States United States, Maryland Baltimore, Maryland, United States United States, New York New York, New York, United States United States, North Carolina Asheville, North Carolina, United States Winston-Salem, North Carolina, United States United States, Ohio Cincinatti, Ohio, United States United States, Pennsylvania Pittsburgh, Pennsylvania, United States United States, Tennessee Germantown, Tennessee, United States Nashville, Tennessee, United States United States, Texas Austin, Texas, United States San Antonio, Texas, United States United States, Virginia Norfolk, Virginia, United States Less <<
NCT01854697 Chronic Hepatitis C Infection Phase 3 Completed - -
NCT01858961 Hepatitis C, Chronic Phase 3 Withdrawn July 2016 Australia, New South Wales ... More >> 1241.37.61002 Boehringer Ingelheim Investigational Site Westmead, New South Wales, Australia Australia, South Australia 1241.37.61001 Boehringer Ingelheim Investigational Site Adelaide, South Australia, Australia Australia, Victoria 1241.37.61003 Boehringer Ingelheim Investigational Site Fitzroy, Victoria, Australia Spain 1241.37.34010 Boehringer Ingelheim Investigational Site Alzira, Spain 1241.37.34005 Boehringer Ingelheim Investigational Site Barcelona, Spain 1241.37.34002 Boehringer Ingelheim Investigational Site L'Hospitalet Llobregat (BCN), Spain 1241.37.34001 Boehringer Ingelheim Investigational Site Madrid, Spain 1241.37.34003 Boehringer Ingelheim Investigational Site Madrid, Spain 1241.37.34004 Boehringer Ingelheim Investigational Site Madrid, Spain 1241.37.34006 Boehringer Ingelheim Investigational Site Valencia, Spain Sweden 1241.37.46002 Boehringer Ingelheim Investigational Site Lund, Sweden 1241.37.46001 Boehringer Ingelheim Investigational Site Stockholm, Sweden Less <<
NCT02006745 HIV Phase 3 Completed - United Kingdom ... More >> St Stephens AIDS Trust London, United Kingdom, SW10 9TH Less <<
NCT00621296 Hepatitis C Phase 2 Completed - Japan ... More >> Toranomon Hospital Kawasaki City, Takatsu-ku, Japan Less <<
NCT01718145 Hepatitis C Virus Infection Phase 3 Completed - Japan ... More >> Local Institution Nagoya-shi, Aichi, Japan, 4668560 Local Institution Toyoake Shi, Aichi, Japan, 4701192 Local Institution Chiba-shi, Chiba, Japan, 2608677 Local Institution Fukuoka-shi, Fukuoka, Japan, 8108563 Local Institution Kurume, Fukuoka, Japan, 8300011 Local Institution Ogaki-shi, Gifu, Japan, 5038502 Local Institution Takasaki City, Gunma, Japan, 3700829 Local Institution Hiroshima-shi, Hiroshima, Japan, 7340037 Local Institution Obihiro-shi, Hokkaido, Japan, 080-0016 Local Institution Sapporo-shi, Hokkaido, Japan, 0600033 Local Institution Sapporo-shi, Hokkaido, Japan, 0608648 Local Institution Takamatsu-shi, Kagawa, Japan, 760-8557 Local Institution Kagoshima-shi, Kagoshima, Japan, 8908520 Local Institution Kawasaki-shi, Kanagawa, Japan, 2138587 Local Institution Yokohama-shi, Kanagawa, Japan, 2360004 Local Institution Kumamoto-shi, Kumamoto, Japan, 8608556 Local Institution Kyoto-shi, Kyoto, Japan, 6028566 Local Institution Sendai-shi, Miyagi, Japan, 9808574 Local Institution Matsumoto, Nagano, Japan, 3908621 Local Institution Nagasaki-shi, Nagasaki, Japan, 8528501 Local Institution Omura, Nagasaki, Japan, 8568562 Local Institution Kashihara, Nara, Japan, 6348522 Local Institution Yufu, Oita, Japan, 8795593 Local Institution Okayama-shi, Okayama, Japan, 7008558 Local Institution Osaka-sayama-shi, Osaka, Japan, 5898511 Local Institution Osaka-shi, Osaka, Japan, 5438555 Local Institution Osaka-shi, Osaka, Japan, 5458586 Local Institution Suita-shi, Osaka, Japan, 5650871 Local Institution Suita, Osaka, Japan, 5640013 Local Institution Iruma-gun, Saitama, Japan, 3500495 Local Institution Izunokuni, Shizuoka, Japan, 4102295 Local Institution Shimotsuke-shi, Tochigi, Japan, 3290498 Local Institution Bunkyo-ku, Tokyo, Japan, 1138519 Local Institution Bunkyo-ku, Tokyo, Japan, 1138655 Local Institution Minato-ku, Tokyo, Japan, 1058470 Local Institution Musashino-shi, Tokyo, Japan, 1808610 Local Institution Shinagawa-ku, Tokyo, Japan, 1428666 Local Institution Yamagata-shi, Yamagata, Japan, 9909585 Local Institution Chuo-shi, Yamanashi, Japan, 4093898 Local Institution Fukui, Japan, 9188503 Local Institution Fukuoka, Japan, 8140180 Local Institution Fukuoka, Japan, 8158555 Local Institution Gifu, Japan, 5008513 Local Institution Kumamoto, Japan, 8628655 Local Institution Nagoya-shi, Japan, 4678602 Local Institution Nishinomiya-shi, Japan, 6638501 Local Institution Osaka, Japan, 5400006 Local Institution Saitama, Japan, 3380001 Less <<
NCT00535847 Hepatitis C Phase 2 Completed - -
NCT00828789 Hepatitis C H... More >>CV HIV AIDS Less << Phase 1 Completed - -
NCT00535847 - Completed - -
NCT01980290 - Completed - Belgium ... More >> Antwerpen, Belgium Brussels, Belgium Bruxelles, Belgium Genk, Belgium Haine-Saint-Paul, Belgium France Lomme, France Montpellier, France Perpignan Cedex, France Germany Berlin, Germany Biberach, Germany Kassel, Germany München, Germany Münster, Germany Netherlands Maastricht, Netherlands Switzerland Lausanne, Switzerland Zürich, Switzerland United Kingdom Dundee, United Kingdom London, United Kingdom Nottingham, United Kingdom Less <<
NCT01080222 Chronic Hepatitis C Virus Infe... More >>ction Less << Phase 2 Terminated(Study discontinued) - -
NCT00336479 Chronic Hepatitis C Phase 2 Completed - -
NCT01598090 Hepatitis C Virus Phase 3 Completed - -
NCT01492426 - Completed - -
NCT01415141 Hepatitis C Phase 4 Withdrawn(Lack of funding) - United States, Georgia ... More >> Emory University School of Medicine Atlanta, Georgia, United States, 30030 United States, Vermont Fletcher Allen Health Care Burlington, Vermont, United States, 05401 Less <<
NCT00336479 - Completed - -
NCT00983853 Hepatitis C H... More >>IV Infections Less << Phase 2 Completed - United States, California ... More >> Beverly Hills, California, United States, 90211 San Diego, California, United States, 92093 San Francisco, California, United States, 94110 United States, Florida Miami, Florida, United States, 33125 Orlando, Florida, United States, 32803 United States, Illinois Chicago, Illinois, United States, 60612 United States, Maryland Baltimore, Maryland, United States, 21287 United States, Massachusetts Boston, Massachusetts, United States, 02114 United States, New York New York, New York, United States, 10029 United States, Ohio Cincinnati, Ohio, United States, 45267 United States, Texas Dallas, Texas, United States, 75204 France Paris, France Germany Bonn-Venusberg, Germany Hamburg, Germany Spain Barcelona, Spain Madrid, Spain Less <<
NCT00933894 Hepatitis C Phase 1 Completed - -
NCT00262483 Hepatitis C Phase 2 Completed - United States, Texas ... More >> Call for information San Antonio, Texas, United States Puerto Rico Call for information Santurce, Puerto Rico Less <<
NCT00973388 Hepatitis C Phase 1 Completed - -
NCT00758043 Hepatitis C Phase 3 Completed - -
NCT00958152 Hepatitis C Phase 1 Completed - New Zealand ... More >> Christchurch, New Zealand Less <<
NCT02881034 - Completed - France ... More >> Hôpital de la Croix Rousse Lyon, France Less <<
NCT01492426 Hepatitis C Phase 3 Completed - -
NCT00758043 - Completed - -
NCT00372385 - Completed - -
NCT00528528 Chronic Hepatitis C Phase 2 Completed - Austria ... More >> Wien, Austria Belgium Brussels, Belgium Bruxelles, Belgium Gent, Belgium Leuven, Belgium Liège, Belgium France Angers Cedex 9, France Clichy, France Grenoble, France Lille Cedex, France Nice, France Paris Cedex 12, France Paris, France Vandoeuvre Les Nancy, France Germany Düsseldorf, Germany Frankfurt N/A, Germany Freiburg, Germany Hamburg, Germany Hannover, Germany Koln, Germany Tübingen, Germany Netherlands Leiden, Netherlands Nijmegen, Netherlands Spain Barcelona, Spain Madrid, Spain Valencia, Spain Less <<
NCT01516918 Chronic Hepatitis C Virus Phase 2 Completed - -
NCT01854697 - Completed - -
NCT01241760 Genotype 1 Chronic Hepatitis C... More >> Treatment Naive Less << Phase 3 Completed - -
NCT00372385 Chronic Hepatitis C Phase 2 Completed - Austria ... More >> Call For Information Call For Information, Austria France Call For Information Call For Information, France Germany Call For Information Call For Information, Germany United Kingdom Call for Information Call for Information, United Kingdom Less <<
NCT00528528 - Completed - -
NCT01467479 Hepatitis C Phase 3 Terminated(It was decided by S... More >>ponsor on 13 January 2014 to terminate study early at primary efficacy endpoint as part of a decision to modify drug development plan.) Less << - -
NCT01241760 - Completed - -
NCT01467505 Hepatitis C Phase 2 Terminated(The study was termi... More >>nated early by the sponsor on 13 January 2014 due to a decision to modify the drug development plan.) Less << - -
NCT01467505 - Terminated(The study was termi... More >>nated early by the sponsor on 13 January 2014 due to a decision to modify the drug development plan.) Less << - -
NCT01467479 - Terminated(It was decided by S... More >>ponsor on 13 January 2014 to terminate study early at primary efficacy endpoint as part of a decision to modify drug development plan.) Less << - -
NCT00420784 Hepatitis C Phase 2 Completed - -
NCT01275599 Hepatitis C O... More >>pioid-Related Disorders Less << Phase 1 Completed - United States, Kansas ... More >> Overland Park, Kansas, United States United States, Utah Salt Lake City, Utah, United States Less <<
NCT00983853 - Completed - -
NCT00420784 - Completed - -
NCT01038167 Hepatitis C Phase 1 Completed - United States, Texas ... More >> Dallas, Texas, United States Less <<
NCT01872936 Hepatitis C, Chronic Phase 2 Unknown January 2015 United States, Texas ... More >> The Liver Institute at Methodist Dallas Medical Center Dallas, Texas, United States, 75203 Research Specialists of Texas Houston, Texas, United States, 77030 Puerto Rico Fundacion de Investigacion de Diego San Juan, Puerto Rico, 00927 Less <<
NCT00627926 Hepatitis C Phase 3 Completed - -
NCT01701063 - Terminated - -
NCT01508286 - - - -
NCT01716403 - Terminated - France ... More >> Grenoble University Hospital Grenoble, France, 38043 Less <<
NCT01701063 Hepatitis C Phase 1 Phase 2 Terminated - -
NCT00703118 Hepatitis C, Chronic Phase 3 Completed - -
NCT01336829 Hepatitis C H... More >>IV Less << Phase 1 Completed - Belgium ... More >> Antwerp, Belgium Less <<
NCT00627926 - Completed - -
NCT01597895 Healthy Phase 1 Completed - Belgium ... More >> Pfizer Investigational Site Bruxelles, Belgium, B-1070 Less <<
NCT01498068 Genotype 1 Chronic Hepatitis C Phase 3 Completed - Russian Federation ... More >> Moscow, Russian Federation Saint-Petersburg, Russian Federation Samara, Russian Federation Smolensk, Russian Federation Stavropol, Russian Federation Less <<
NCT02113631 Hepatitis C, Chronic ... More >> Cirrhosis Less << Not Applicable Completed - United States, Ohio ... More >> Louis Stokes Cleveland VA medical center Cleveland, Ohio, United States, 44106 Less <<
NCT01635829 Healthy Participants Phase 1 Completed - Netherlands ... More >> Groningen, Netherlands Less <<
NCT01498068 - Completed - -
NCT00580801 Hepatitis C Phase 2 Completed - -
NCT00580801 - Completed - -
NCT01253551 Hepatitis C Phase 1 Completed - -
NCT01766115 Viral Hepatitis C PHASE4 WITHDRAWN 2025-05-14 Massachusetts General Hospital... More >>, Boston, Massachusetts, 02114, United States Less <<
NCT01571583 Chronic Hepatitis C Virus (HCV... More >>) Infection Less << Phase 3 Completed - Austria ... More >> Linz, Austria Wien, Austria Belgium Brussels, Belgium Gent, Belgium Leuven, Belgium Liege, Belgium France Clichy, France Marseille, France Montpellier, France Rennes Cedex N/A, France Villejuif Cedex, France Germany Essen, Germany Frankfurt A. M., Germany Hannover, Germany Leipzig, Germany Münster, Germany Spain Barcelona, Spain Madrid, Spain Valencia, Spain United Kingdom Birmingham, United Kingdom London, United Kingdom Less <<
NCT01513941 Chronic Hepatitis C Phase 3 Completed - Australia ... More >> Cairns, Australia Darlinghurst, Australia Melbourne, Australia Brazil Campinas, Brazil Rio De Janeiro, Brazil Santo André, Brazil Sao Paulo, Brazil France Le Kremlin Bicetre, France Marseille, France Nice N/A, France Paris Cedex 12, France Poland Bydgoszcz, Poland Myslowice, Poland Warszawa, Poland Russian Federation Krasnodar, Russian Federation Perm, Russian Federation Saint-Petersburg, Russian Federation Smolensk, Russian Federation St Petersburg, Russian Federation Voronezh, Russian Federation Spain Alicante, Spain Badalona, Spain Cordoba, Spain Elche, Spain Madrid, Spain San Sebastian, Spain Sevilla N/A, Spain Valencia, Spain Sweden Stockholm, Sweden United Kingdom Birmingham, United Kingdom Glasgow, United Kingdom London, United Kingdom Less <<
NCT00703118 - Completed - -
NCT01657552 Thrombocytopaenia Phase 1 Completed - United States, Maryland ... More >> GSK Investigational Site Baltimore, Maryland, United States, 21225 Less <<
NCT01054573 Hepatitis C, Chronic Phase 3 Completed - -
NCT01054573 - Completed - -
NCT00892697 - Completed - -
NCT01511432 Chronic Hepatitis C Phase 1 Completed - United States, Texas ... More >> Texas Dallas, Texas, United States, 75247 United States, Wisconsin Wisconsin Madison, Wisconsin, United States, 53704 Less <<
NCT01890772 Hepatitis C Phase 2 Phase 3 Withdrawn - United States, California ... More >> VA Long Beach Healthcare System Long Beach, California, United States, 90822 United States, Minnesota Minneapolis VAHCS Minneapolis, Minnesota, United States, 55417 United States, Missouri Kansas City VA Medical Center Kansas City, Missouri, United States, 64128 United States, Pennsylvania Philadelphia VA Medical Center Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT01467492 Hepatitis C Phase 4 Terminated(It was decided by S... More >>ponsor on 13 January 2014 to terminate study early at primary efficacy endpoint as part of a decision to modify drug development plan.) Less << - -
NCT01592006 - Terminated(Low accrual) - -
NCT00892697 Hepatitis C Phase 2 Completed - -
NCT01459913 Hepatitis C, Chronic Phase 3 Terminated(The study was termi... More >>nated early by the sponsor on 13 January 2014 due to a decision to modify the drug development plan.) Less << - -
NCT00916474 - Completed - -
NCT01592006 Hepatitis C Phase 4 Terminated(Low accrual) - United States, Illinois ... More >> University of Chicago Medical Center Chicago, Illinois, United States, 60637 Less <<
NCT01459913 - Terminated(The study was termi... More >>nated early by the sponsor on 13 January 2014 due to a decision to modify the drug development plan.) Less << - -
NCT01818856 Hepatitis C, Chronic ... More >> HIV Infection Less << Phase 1 Completed - Spain ... More >> Hospital Universitario Virgen del Rocio Seville, Spain, 41013 Less <<
NCT00775125 Hepatitis C T... More >>elaprevir HIV Less << Phase 1 Completed - -
NCT00561015 - Completed - -
NCT00561015 Hepatitis C, Chronic Phase 2 Completed - France ... More >> Clichy, France Creteil N/A, France Lyon, France Paris, France Vandoeuvre Les Nancy, France Sweden Stockholm, Sweden United Kingdom London, United Kingdom Less <<
NCT01467492 - Terminated(It was decided by S... More >>ponsor on 13 January 2014 to terminate study early at primary efficacy endpoint as part of a decision to modify drug development plan.) Less << - -
NCT01821963 Infection Phase 3 Terminated(Low referral rate d... More >>ue to new therapeutic options.) Less << - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00903773 Hepatitis C K... More >>idney Diseases Less << Phase 1 Completed - -
NCT01332955 Hepatitis C, Chronic ... More >> HIV Infection Less << Phase 2 Completed - France ... More >> Service Maladies Infectieuses et Tropicales, Hôpital de la Croix-Rousse Lyon, France Less <<
NCT02087111 Hepatitis C Phase 4 Unknown June 2015 United Kingdom ... More >> Bradford Teaching Hospitals NHS Foundation Trust Not yet recruiting Bradford, United Kingdom, BD9 6RJ Contact: Sulleman Moreea       Sulleman.Moreea@bthft.nhs.uk    Principal Investigator: Sulleman Moreea          Barts Health NHS Trust Not yet recruiting London, United Kingdom, E1 1BB Contact: Graham R Foster    02078827242    g.r.foster@qmul.ac.uk    Contact: Sampath DeSilva       sampath81@doctors.org.uk    Principal Investigator: Graham R Foster          Sub-Investigator: Sampath DeSilva          Ste Georges Healthcare NHS Trust Not yet recruiting London, United Kingdom, SW17 0QT Contact: Daniel Forton       daniel.forton@nhs.net    Principal Investigator: Daniel Forton          Nottingham University Hospitals Trust Not yet recruiting Nottingham, United Kingdom, NG7 2UH Contact: Stephen Ryder       Stephen.Ryder@nuh.nhs.uk    Principal Investigator: Stephen Ryder Less <<
NCT00933283 Healthy Participants Phase 1 Completed - -
NCT01500616 Hepatitis C, Chronic Phase 3 Completed - Belgium ... More >> Antwerpen, Belgium Brussel, Belgium Bruxelles, Belgium Charleroi, Belgium Gent, Belgium Leuven, Belgium Liège, Belgium Germany Berlin, Germany Bonn, Germany Dortmund, Germany Frankfurt, Germany Hannover, Germany Köln, Germany Stuttgart, Germany Tübingen, Germany Hungary Budapest, Hungary Ireland Dublin, Ireland Luxembourg Luxembourg, Luxembourg Portugal Amadora, Portugal Lisboa, Portugal Lisbon, Portugal Porto, Portugal Russian Federation Perm, Russian Federation Saint-Petersburg, Russian Federation St Petersburg, Russian Federation Toliatti, Russian Federation Volgograd, Russian Federation Yoshkar - Ola, Russian Federation United Kingdom Glasgow, United Kingdom Liverpool, United Kingdom London, United Kingdom Plymouth, United Kingdom Less <<
NCT01646489 Hepatitis C C... More >>hronic Hepatitis C Less << Phase 1 Completed - United States, Wisconsin ... More >> Spaulding Clinical Research West Bend, Wisconsin, United States, 53095 Less <<
NCT01821963 - Terminated(Low referral rate d... More >>ue to new therapeutic options.) Less << - -
NCT01994486 Hepatitis C, Chronic Phase 2 Completed - United States, Florida ... More >> UF Hepatology Research at CTRB Gainesville, Florida, United States, 32610 Less <<
NCT01600976 Hepatic Impairment Phase 1 Completed - Czech Republic ... More >> Praha 7, Czech Republic Germany Kiel, Germany Less <<
NCT01994486 - Completed - -
NCT01841502 Hepatitis C Infection ... More >> Depression Less << Phase 2 Terminated(Telaprevir will not... More >> be used in NL, no more inclusions are expected.) Less << - Netherlands ... More >> Academic Medical Centre Amsterdam Amsterdam, Netherlands GGD Amsterdam Amsterdam, Netherlands Reinier de Graaf Groep Delft, Netherlands University Medical Centre Groningen Groningen, Netherlands Radboud University Nijmegen Medical Centre Nijmegen, Netherlands Maasstadziekenhuis Rotterdam, Netherlands University Medical Centre Utrecht Utrecht, Netherlands Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.47mL

0.29mL

0.15mL

7.35mL

1.47mL

0.74mL

14.71mL

2.94mL

1.47mL

References

 

Historical Records

Categories